Drug
Nyx 458
Nyx 458: highest development phase Phase 2, developed by Aptinyx. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Aptinyx
Trials
| Drug | Phase | Indication |
|---|---|---|
| NYX-458 NCT04148391 | Phase 2 | Mild Cognitive Impairment |
Latest
No recent events.
Follow Nyx 458 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.